Corporate News

Result of AGM

28 June 2024

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that at the Annual General Meeting ('AGM') of the Company held earlier today, all resolutions put to the Company's shareholders were duly passed.

(*indicates special resolution)
Votes for% of shares votedVotes against% of shares voted
Resolution 1 8,464,640 99.6% 31,692 0.4%
Resolution 2 8,421,681 99.5% 44,241 0.5%
Resolution 3 8,425,848 99.2% 68,588 0.8%
Resolution 4 8,448,906 99.5% 45,530 0.5%
Resolution 5 1,620,012 95.2% 81,563 4.8%
Resolution 6* 1,361,538 80.0% 340,267 20.0%
Resolution 7* 8,451,080 99.5% 46,232 0.5%



The full text of, inter alia, the resolutions proposed and passed at the AGM can be found in the Company's Notice of Annual General Meeting which was published and posted to Shareholders on 4 June 2024 and is available on the Company's website at


For further information contact:

Penny McCormick, Chief Executive Officervia Walbrook PR
SPARK Advisory Partners Limited (NOMAD)Tel: +44 (0)20 3368 3550
Neil Baldwin / Jade Bayat 
Dowgate Capital Limited (Broker)Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers 
Walbrook PR Ltd (Media & IR)Tel: +44 (0)20 7933 8780 or [email protected]
Paul McManus / Alice WoodingsMob: +44 (0)7980 541 893 / +44(0)7407 804 654


About MyHealthChecked PLC (

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.